CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,222 | +37.2% | 12,900 | 0.0% | 0.00% | – |
| Q2 2023 | $4,536 | -65.2% | 12,900 | -79.5% | 0.00% | – |
| Q1 2023 | $13,020 | -24.1% | 62,900 | +93.4% | 0.00% | – |
| Q4 2022 | $17,154 | -25.4% | 32,520 | -29.5% | 0.00% | – |
| Q3 2022 | $23,000 | -60.3% | 46,120 | +41.9% | 0.00% | – |
| Q2 2022 | $58,000 | +176.2% | 32,500 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | -30.0% | 32,500 | -0.9% | 0.00% | – |
| Q4 2021 | $30,000 | -94.4% | 32,800 | -74.7% | 0.00% | – |
| Q3 2021 | $532,000 | -9.1% | 129,553 | -4.1% | 0.00% | -100.0% |
| Q2 2021 | $585,000 | -9.2% | 135,129 | +5.8% | 0.00% | 0.0% |
| Q1 2021 | $644,000 | -39.6% | 127,703 | -24.4% | 0.00% | 0.0% |
| Q4 2020 | $1,066,000 | +238.4% | 168,918 | +130.8% | 0.00% | – |
| Q3 2020 | $315,000 | -9.5% | 73,202 | +23.6% | 0.00% | – |
| Q2 2020 | $348,000 | -40.5% | 59,202 | +38.0% | 0.00% | -100.0% |
| Q4 2017 | $585,000 | – | 42,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |